Inventor · disambiguated record
Anil Chhettry
Also filed as: CHHETTRY ANIL
8 granted patents·31 pending applications·17 citations·filing 2005–2024
83Inventor score
Files withFOREST LAB HOLDINGS LTD14FOREST LABORATORIES5FOREST LABORATORIES HOLDINGS LTD5IRONWOOD PHARMACEUTICALS INC5RICHTER GEDEON NYRT5
Top patents by PatentIndex Score
39 records- 0191USRE47350EPharmaceutical formulations containing dopamine receptor ligandsRICHTER GEDEON NYRT·Filed 2017·Granted Apr 16, 2019·4 cites·10 claims
- 0291USRE47333EPharmaceutical formulations containing dopamine receptor ligandsRICHTER GEDEON NYRT·Filed 2017·Granted Apr 2, 2019·4 cites·10 claims
- 0388US9056846B2Pharmaceutical formulations containing dopamine receptor ligandsRICHTER GEDEON NYRT·Filed 2012·Granted Jun 16, 2015·4 cites·10 claims
- 0485USRE49110EPharmaceutical formulations containing dopamine receptor ligandsRICHTER GEDEON NYRT·Filed 2019·Granted Jun 21, 2022·1 cites·11 claims
- 0583US9056845B2Pharmaceutical formulations containing dopamine receptor ligandsSARKAR RANAJOY·Filed 2009·Granted Jun 16, 2015·4 cites·10 claims
- 0679US2025073301A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0775US2023398173A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0874USRE49302EPharmaceutical formulations containing dopamine receptor ligandsRICHTER GEDEON NYRT·Filed 2019·Granted Nov 15, 2022·0 cites·15 claims
- 0973US2023142270A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1065US2013302430A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 1163US2016310559A1Delayed Release Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1261US2013253063A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 1361US2015065582A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 1461US2018028476A1Stable dosage forms of levomilnacipranFOREST LABORATORIES HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 1560US2012201889A1Modified and immediate release formulations of memantineDEDHIYA MAHENDRA G·Filed 2012·Application pending·0 cites
- 1660US2016346227A1Modified and immediate release formulations of memantineFOREST LABORATORIES HOLDINGS LTD·Filed 2016·Application pending·0 cites
- 1760US2008008743A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2007·Application pending·0 cites
- 1860US2015258042A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 1957US2014057954A1Chemical compositionFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2057US2007065512A1Modified and immediate release formulations of memantineFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 2157US2013011474A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
- 2255US2015148424A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 2354US2017172942A1Orally dissolving formulations of memantineFOREST LABORATORIES HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 2454US2015031632A1Orally Disintegrating Compositions of LinaclotideFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 2552US8481598B2Stable dosage forms of levomilnacipranSURANA RAHUL·Filed 2011·Granted Jul 9, 2013·0 cites·8 claims
- 2652US2011046232A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2010·Application pending·0 cites
- 2751US2015238442A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 2849US10441536B2Micronized colistimethane sodium pharmaceutical compositionsFOREST LABORATORIES HOLDINGS LTD·Filed 2014·Granted Oct 15, 2019·0 cites·4 claims
- 2949US2015148388A1Chemical compositionFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 3049US2006165789A1Lercanidipine modified release compositionsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 3148US2020253901A1Stable dosage forms of levomilnacipranFOREST LABORATORIES HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 3248US2006134212A1Lercanidipine immediate release compositionsFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 3346US2006165788A1Lercanidipine pH dependent pulsatile release compositionsABRAMOWITZ WATTANAPORN·Filed 2005·Application pending·0 cites
- 3446US2014023710A1Milnacipran formulationsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3544US2007134322A1Modified and pulsatile release pharmaceutical formulations of escitalopramFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 3643US2007112075A1Stable pharmaceutical formulations containing escitalopram and bupropionFOREST LABORATORIES·Filed 2006·Application pending·0 cites
- 3739US2016015638A1Stable glucokinase activator compositionsVTV THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
- 3839US2010286260A1Milnacipran formulationsFOREST LAB HOLDINGS LTD·Filed 2010·Application pending·0 cites
- 3936US2013012454A1Orally Disintegrating Compositions of LinaclotideIRONWOOD PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anil Chhettry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →